|
| Domain | ID | Description | value |
|
| BP | GO: 0031667 | Response to nutrient levels | 3.35E−19 |
| BP | GO: 0062197 | Cellular response to chemical stress | 9.33E−19 |
| BP | GO: 0007568 | Aging | 2.74E−18 |
| BP | GO: 0006979 | Response to oxidative stress | 3.91E−18 |
| BP | GO: 0033002 | Muscle cell proliferation | 2.50E−17 |
| BP | GO: 0042493 | Response to drug | 1.31E−16 |
| BP | GO: 0000302 | Response to reactive oxygen species | 4.22E−16 |
| BP | GO: 0048608 | Reproductive structure development | 8.94E−16 |
| BP | GO: 0009636 | Response to toxic substance | 2.80E−14 |
| BP | GO: 0070482 | Response to oxygen levels | 5.06E−14 |
| CC | GO: 0045121 | Membrane raft | 4.79E−08 |
| CC | GO: 0098857 | Membrane microdomain | 4.93E−08 |
| CC | GO: 0098589 | Membrane region | 7.07E−08 |
| CC | GO: 0005635 | Nuclear envelope | 1.45E−07 |
| CC | GO: 0031983 | Vesicle lumen | 5.65E−07 |
| CC | GO: 0005769 | Early endosome | 1.79E−06 |
| CC | GO: 0005667 | Transcription regulator complex | 3.78E−06 |
| CC | GO: 0000307 | Cyclin-dependent protein kinase holoenzyme complex | 8.44E−06 |
| CC | GO: 0090575 | RNA polymerase II transcription regulator complex | 8.90E−06 |
| CC | GO: 0009925 | Basal plasma membrane | 1.68E−05 |
| MF | GO: 0019902 | Phosphatase binding | 1.00E−12 |
| MF | GO: 0019903 | Protein phosphatase binding | 4.10E−11 |
| MF | GO: 0031625 | Ubiquitin protein ligase binding | 4.17E−07 |
| MF | GO: 0042277 | Peptide binding | 5.66E−07 |
| MF | GO: 0004879 | Nuclear receptor activity | 6.69E−07 |
| MF | GO: 0098531 | Ligand-activated transcription factor activity | 6.69E−07 |
| MF | GO: 0044389 | Ubiquitin-like protein ligase binding | 7.01E−07 |
| MF | GO: 0140297 | DNA-binding transcription factor binding | 1.52E−06 |
| MF | GO: 0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 2.11E−06 |
| MF | GO: 0001223 | Transcription coactivator binding | 2.15E−06 |
| KEGG | hsa01522 | Endocrine resistance | 1.79E−21 |
| KEGG | hsa05219 | Bladder cancer | 5.14E−21 |
| KEGG | hsa05215 | Prostate cancer | 6.44E−20 |
| KEGG | hsa05212 | Pancreatic cancer | 8.38E−17 |
| KEGG | hsa05417 | Lipid and atherosclerosis | 1.90E−16 |
| KEGG | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 4.77E−15 |
| KEGG | hsa05163 | Human cytomegalovirus infection | 8.07E−15 |
| KEGG | hsa04066 | HIF-1 signaling pathway | 4.28E−13 |
| KEGG | hsa05207 | Chemical carcinogenesis—receptor activation | 8.16E−13 |
| KEGG | hsa04151 | PI3K-Akt signaling pathway | 1.78E−12 |
|
